Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Droescher

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neuromolecular Medicine|August 31, 2013
SUMO rules: regulatory concepts and their implication in neurologic functionsMathias Droescher, Viduth K Chaugule, Andrea Pichler
Blood|June 4, 2011
SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγAndreas Begitt, Mathias Droescher, Klaus-Peter Knobeloch, et al.
The Journal of Biological Chemistry|April 5, 2011
Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO)Mathias Droescher, Andreas Begitt, Andreas Marg, et al.
The International Journal of Biochemistry & Cell Biology|June 26, 2016
The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stabilityStefanie Koidl, Nathalie Eisenhardt, Chronis Fatouros, et al.
Nature Immunology|January 14, 2014
STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signalingAndreas Begitt, Mathias Droescher, Thomas Meyer, et al.
Nature Structural & Molecular Biology|November 3, 2015
A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assemblyNathalie Eisenhardt, Viduth K Chaugule, Stefanie Koidl, et al.
Translational Stroke Research|June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery OcclusionPeer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Neurobiology of Disease|May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primatesPeer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Heliyon|September 10, 2024
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primatesEdward F Greenberg, Martin J Voorbach, Alexandra Smith, et al.
Cell Reports. Medicine|September 13, 2022
A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiencyOlav M Andersen, Nikolaj Bøgh, Anne M Landau, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuromolecular Medicine|August 31, 2013
SUMO rules: regulatory concepts and their implication in neurologic functionsMathias Droescher, Viduth K Chaugule, Andrea Pichler
Blood|June 4, 2011
SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγAndreas Begitt, Mathias Droescher, Klaus-Peter Knobeloch, et al.
The Journal of Biological Chemistry|April 5, 2011
Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO)Mathias Droescher, Andreas Begitt, Andreas Marg, et al.
The International Journal of Biochemistry & Cell Biology|June 26, 2016
The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stabilityStefanie Koidl, Nathalie Eisenhardt, Chronis Fatouros, et al.
Nature Immunology|January 14, 2014
STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signalingAndreas Begitt, Mathias Droescher, Thomas Meyer, et al.
Nature Structural & Molecular Biology|November 3, 2015
A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assemblyNathalie Eisenhardt, Viduth K Chaugule, Stefanie Koidl, et al.
Translational Stroke Research|June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery OcclusionPeer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Neurobiology of Disease|May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primatesPeer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Heliyon|September 10, 2024
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primatesEdward F Greenberg, Martin J Voorbach, Alexandra Smith, et al.
Cell Reports. Medicine|September 13, 2022
A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiencyOlav M Andersen, Nikolaj Bøgh, Anne M Landau, et al.
Pageof 2